Induction of angiogenesis by normal and malignant plasma cells. - Wikidata - awgldk - TriplyDB

Induction of angiogenesis by normal and malignant plasma cells.

Induction of angiogenesis by normal and malignant plasma cells.

http://www.wikidata.org/entity/Q39870744

about

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors Ex-vivo dynamic 3-D culture of human tissues in the RCCS™ bioreactor allows the study of Multiple Myeloma biology and response to therapy Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.Cyclin K and cyclin D1b are oncogenic in myeloma cells.Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.Microvesicles secreted from human multiple myeloma cells promote angiogenesis.The glycome of normal and malignant plasma cells Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection.Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1 Matricellular proteins as regulators of cancer metastasis to bone.The molecular characterization and clinical management of multiple myeloma in the post-genome era.Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma.Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.The microenvironment in mature B-cell malignancies: a target for new treatment strategies Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies.Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.Biological aspects of angiogenesis in multiple myeloma.Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.Targeting the bone marrow microenvironment in multiple myeloma.The role of CCN family genes in haematological malignancies.Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients.Angiogenesis and multiple myeloma.Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma.Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma.Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease.Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma.Sorafenib in patients with refractory or recurrent multiple myeloma.

P2860

Q28075927-267CAF8D-C432-4011-8504-7725F0C94288 Q28077635-C869F7CE-5354-443F-8E90-C4F106DFE285 Q28487743-BA785714-7D6F-40E3-B632-AB337312896C Q28535634-4E268331-A45B-408A-B46F-EAF6B03DBDCD Q33587558-22A9043E-3ECF-48BA-9F2A-8CF4F5EB0FB2 Q33748979-C3E41BB9-2C17-4B05-9927-457D8CB69F69 Q33895292-C041BD20-A975-46A4-9723-E69679FB1D9A Q33938595-F82CDBBA-8521-481C-846A-A8293FE78C2F Q34451553-F37EAB04-C43E-46FF-B330-4DA52D141A70 Q35077269-BC9E1498-C022-4E72-BE98-99794EBC5758 Q35080602-3FE90F2C-9C12-4E73-BB31-A82CCCD2C3BD Q35097641-D18A9E1A-B674-4F4E-8AAE-4AA5F48B097C Q35244865-F5779449-A62A-4169-A9BC-6A698E8070AA Q36099378-D0B90958-C659-4808-89AE-06A2C7E8045C Q36579136-9D5C2F23-4C97-4E5A-939A-23A144BEF089 Q36717999-B6A82ADB-07E6-48A5-B744-6A8DE456333B Q36923653-1270932C-8601-4683-BC93-86409B1E2D40 Q36939043-BE4150D6-8DBC-4776-855B-A14A96D641B6 Q37144899-563D44EC-5907-491D-A0B0-EC3DCE2BE542 Q37373624-60E76965-9309-4CD8-A701-B8B0FE7826BE Q37563816-0099DAD3-7E3A-4A19-9C24-92FCF1AB3F54 Q37760210-F2A2CEBB-387B-4451-B90D-4208C9F78DB5 Q37761370-CFA74014-3259-4407-B8CF-CFAEBF6245D5 Q37956524-C1670230-00DB-4CE4-A0ED-5FEB770A4D86 Q38008379-C3B09974-B11C-477B-BFC8-DF3673ECC272 Q38289041-985CC926-F157-4587-BFDF-88FCE8D100E0 Q38508845-DF58823B-FDDB-431E-99F8-2B686D96C999 Q38588911-369B6C9D-B691-44D9-958D-D166AE6CED31 Q38673891-CB019FBC-3BBE-4B5B-84E3-27930CDCA2B4 Q38910971-9F724DB9-D2CD-4538-BEC0-8EA60231260E Q39030703-9D0421F7-73B6-4F6E-BCE1-E1E04B8E1188 Q39616165-E7BFD660-2095-4C9A-AC7C-EF86F136CDA4 Q39696428-330DA8B6-561B-41D1-A04D-84A7AA8C4E46 Q40274316-9CBB1535-17A4-46AB-8FCD-DAE5F9135A84 Q40691084-902A50BF-D946-492D-AA0F-F2186CD10D9F Q42324181-9736CBEF-55D6-4B3C-B052-EB5EF4618E45 Q43067059-A19130C5-8007-4E5E-B8E7-12152EBA942B Q43483788-68FDB781-F168-4912-BC13-0ECF4BB9F1A0 Q43647817-83E64A9E-F636-441D-B17A-19C8379FF89A Q44579838-952BE959-1D07-4FD5-86E5-9F66F8387E2F

P2860

Induction of angiogenesis by normal and malignant plasma cells.

http://www.wikidata.org/entity/Q39870744

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Induction of angiogenesis by normal and malignant plasma cells.

@en

Induction of angiogenesis by normal and malignant plasma cells.

@nl

type

label

Induction of angiogenesis by normal and malignant plasma cells.

@en

Induction of angiogenesis by normal and malignant plasma cells.

@nl

prefLabel

Induction of angiogenesis by normal and malignant plasma cells.

@en

Induction of angiogenesis by normal and malignant plasma cells.

@nl

P1433

Q39870744-55A15DE7-CA28-4FC5-8464-1D2483D13BB6

P1476

Q39870744-B98A4B03-715F-427A-8BF1-A5A1E81CDF57

P2093

Q39870744-148C0B7D-716F-48D4-AC7E-4C68B45798CC

Q39870744-2BB33FC3-6741-4F02-9217-8D5256D5DFE4

Q39870744-441B8062-2AB7-4849-9F68-83EAE46FB209

Q39870744-47983E95-0C56-4505-9A07-608E43150E91

Q39870744-4B164DF6-3392-4AF5-9362-CE6D170801CC

Q39870744-4F3D72C4-8614-4032-B27E-CBCE73562098

Q39870744-73746602-16D0-493B-8FAD-B3D02D39D08C

Q39870744-80A23C15-4792-4664-9796-31F6E521F5B6

Q39870744-BA172212-E183-4EA0-AB0F-5764E8E6CF78

Q39870744-C4AB153B-8E8E-4BBD-8621-07562502E53B

P304

Q39870744-3220032B-4E4F-4774-9689-4230A0F99087

P31

Q39870744-F07B1EB6-E237-4C5D-8988-BEE268E0C64A

P356

Q39870744-DA27F71A-8CD6-45B7-9693-553276E686A6

P407

Q39870744-B2604099-6223-486D-AC53-7809C378A535

P433

Q39870744-D42E6290-3C14-4A5B-ACDE-D240E194382C

P478

Q39870744-DD5CF57D-5EA1-46E4-ACDA-F4ECDF5E6D1B

P50

Q39870744-29DBA517-417F-431C-A7E1-A78092AE31F6

Q39870744-82527D4C-63D8-4E23-9741-756484979CE4

Q39870744-997D20D7-7770-493E-AD26-E1F98DF4EC49

Q39870744-C65B7368-4594-4E5B-971F-1BF26C55F824

P577

Q39870744-DAD34001-7D6D-40AC-A4BC-F38757563DE1

P5875

Q39870744-2C40A111-4466-4192-A617-0BD65680CA45

P698

Q39870744-19A3A42B-963A-4DC2-A5DB-8698D2E418E5

P356

BLOOD-2008-10-184226

P1433

P1476

Induction of angiogenesis by normal and malignant plasma cells

@en

P2093

Anja Seckinger

http://www.w3.org/2001/XMLSchema#string

Anna Jauch

http://www.w3.org/2001/XMLSchema#string

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Bernard Klein

http://www.w3.org/2001/XMLSchema#string

Dirk Hose

http://www.w3.org/2001/XMLSchema#string

Jean-François Rossi

http://www.w3.org/2001/XMLSchema#string

Jens Hillengass

http://www.w3.org/2001/XMLSchema#string

Karène Mahtouk

http://www.w3.org/2001/XMLSchema#string

Maud Condomines

http://www.w3.org/2001/XMLSchema#string

Michael Hundemer

http://www.w3.org/2001/XMLSchema#string

P304

128-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-10-184226

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut Goldschmidt

Tobias Meißner

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24213219

http://www.w3.org/2001/XMLSchema#string

P698

19299335

http://www.w3.org/2001/XMLSchema#string